Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-FU and LMW Heparin for Retinal Redetachment in PVR
NCT00371020Phase 3Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2005
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of fluorouracil and low molecular weight heparin calcium in Proliferative Vitreoretinopathy (PVR) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Rate of Retinal Redetachment. Status: unknown.
02
Drugs
fluorouracillow molecular weight heparin calcium
03
Conditions
Proliferative Vitreoretinopathy (PVR)
Beyond the preview
Go deeper on NCT00371020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00371020.